Causes of mortality in individuals with tuberous sclerosis complex
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aim: The causes of death in patients with tuberous sclerosis complex (TSC) have rarely been studied, with only one published account, which was reported from the Mayo Clinic in 1991. We aimed to investigate mortality in a large cohort of patients with TSC from one of two national referral clinics in the UK. Method: We identified 284 patients who attended Bath TSC clinic between 1981 and 2015, and ascertained causes of death by reviewing medical records, death certificates, and postmortem reports. Results: Sixteen patients died from complications of TSC: eight from TSC kidney diseases; four from sudden unexpected death in epilepsy (SUDEP); two from lymphangioleiomyomatosis; one from a subependymal giant cell astrocytoma; and one from a pancreatic malignancy. The median age of death was 33 years (interquartile range [IQR] 26–46). Mortality was significantly more common in patients with learning disabilities than in those without (13/135 [9%] vs 3/131 [2%]; two‐tailed Fisher exact test p=0.020). Interpretation: Renal disease is a major cause of mortality in TSC. Lifelong surveillance and early intervention is warranted. SUDEP is also an important cause of mortality. Patients with learning disabilities are at significantly greater risk of early mortality and this implies the need for greater vigilance for TSC‐related complications in this group. Female patients are vulnerable to pulmonary and renal disease. Pancreatic lesions are a rare but potentially treatable cause of mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648 · cited 1×
“Tuberous sclerosis complex (TSC) is a genetic condition caused by mutations in the tumour suppressor genes TSC1 and TSC2, located on chromosomes 9 and 16 respectively.(1,2) Approximately two-thirds of cases occur sporadically and the overall incidence has been estimated to be 1 per 5800 live births.”
BackgroundSelf-citationIdentification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Northrup, H., Krueger, D. A., Northrup, H., Krueger, D. A., Roberds, S., Smith, K., Sampson, J., Korf, B., Kwiatkowski, D. J., Mowat, D., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.001 · Cited by 1,502
Self-citationTee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827 · cited 1×
“The protein products of TSC1 and TSC2 – hamartin and tuberin respectively – function together within the cell and have an inhibitory effect on the mammalian target of rapamycin (mTOR), a protein kinase that influences cell growth and division through the regulation of protein formation.(4) Pathogenic mutations in TSC1…”
BackgroundSensitivity and Specificity of Death Certificates for Diabetes
Cheng, W. S., Wingard, D. L., Kritz-Silverstein, D., & Barrett-Connor, E. (2008) · Diabetes Care · doi:10.2337/dc07-1327 · Cited by 66
Cited by
Thiele, E. A., Bebin, E. M., Bhathal, H., Jansen, F. E., Kotulska, K., Lawson, J. A., O'Callaghan, F. J., Wong, M., Sahebkar, F., Checketts, D., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4607 · Cited by 281
Self-citationEverolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial
Franz, D. N., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D. J., Voi, M., et al. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000514 · Cited by 108
Specchio, N., Nabbout, R., Aronica, E., Auvin, S., Benvenuto, A., de Palma, L., Feucht, M., Jansen, F., Kotulska, K., Sarnat, H., et al. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.08.005 · Cited by 58
Peron, A., Vignoli, A., Briola, F. L., Morenghi, E., Tansini, L., Alfano, R. M., Bulfamante, G., Terraneo, S., Ghelma, F., Banderali, G., et al. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.02.005 · Cited by 36
The extent of kidney involvement in paediatric tuberous sclerosis complex
Limavady, A., & Marlais, M. (2024) · Pediatric Nephrology · doi:10.1007/s00467-024-06417-2 · Cited by 5
“Although TSC kidney disease emerges later in childhood and increases with age [5], it is the leading cause of mortality in adults [6]; thus, childhood presents a window of opportunity to initiate kidney prevention strategies and avert progression to chronic kidney disease (CKD), hypertension, and…”
BackgroundLimavady, A., & Marlais, M. (2024) · European Journal of Pediatrics · doi:10.1007/s00431-024-05520-8 · Cited by 4
Metadata
- Authors
- Amin, S., Lux, A., Calder, N., Laugharne, M., Osborne, J., & O'callaghan, F.
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 2016-12-09
- Volume
- 59
- Issue
- 6
- Pages
- 612-617
- ISSN
- 0012-1622 (ISSN-L)
- 1469-8749
- OpenAlex
- W2560747241
- Cited by
- 133
- References
- 5
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.